← Open Payments lookup

JESUS BUCARDO: Open Payments

NPI 1861581993 · HEMET, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$556 in 18 payments from 10 companies in 2025. Trend: 2023 $643 · 2024 $1,198 · 2025 $556

Food & beverage: $556
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$234
Alkermes, Inc.3$70
ABBVIE INC.2$44
Teva Pharmaceuticals USA, Inc.2$42
Otsuka America Pharmaceutical, Inc.2$42
Vanda Pharmaceuticals Inc.1$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$29
Axsome Therapeutics, Inc.1$22
E.R. Squibb & Sons, L.L.C.1$22
Lundbeck LLC1$17

Products named: INGREZZA, ARISTADA, VRAYLAR, REXULTI, FANAPT, CAPLYTA, AUSTEDO XR, Auvelity.

Industry payments across CA — which companies pay providers there.